GET DAILY SIGNALSMetLife (MET) Delivers Strong Q3 2026 Results with +187% Net Income Growth
Key Takeaways
- MetLife reported third quarter 2026 net income of $2.4 billion, or $3.67 per share, up 187% from the prior-year period.
- Adjusted earnings rose 12% to $1.8 billion, with adjusted earnings per share (EPS) of $2.78, roughly in line with analyst consensus estimates.
- Total revenue reached $20.52 billion, up 14.6% year over year and above Wall Street expectations of roughly $19.8 billion to $19.9 billion.
- Net premiums earned of $11.82 billion came in below consensus of about $12.32 billion, a softer spot in an otherwise strong quarter.
- Book value per share climbed 35.6% year over year to $59.41, while adjusted return on equity (ROE) came in at 19.2%.
Why MetLife’s Results Matter
MetLife stands as one of the world’s largest insurance and financial services companies, with operations spanning the United States, Asia, Latin America, Europe, and the Middle East. Its quarterly updates provide a useful window into global demand for life insurance, annuities, employee benefits, and asset management. The third-quarter 2026 report followed several periods of beating expectations, which raised the bar. With interest rates and investment markets playing key roles in insurer profitability, this release offered clues on whether volume growth, underwriting discipline, and variable investment income could hold steady. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The combination of a revenue beat and a premiums miss made the results especially telling about the quality of growth.
Breaking Down the Reported Numbers
For the third quarter of fiscal 2026, ended September 30, 2026, MetLife posted net income of $2.4 billion, or $3.67 per share, marking a 187% increase from the prior-year period. Adjusted earnings, the figure management and analysts track most closely, rose 12% to $1.8 billion. Adjusted EPS came in at $2.78, essentially matching consensus estimates near $2.75 to $2.77.
Total revenue increased 14.6% year over year to $20.52 billion, exceeding analyst expectations of roughly $19.8 billion to $19.9 billion. Net premiums earned totaled $11.82 billion, however, falling slightly below consensus of about $12.32 billion and remaining roughly flat year over year. Book value per share rose 35.6% to $59.41, and adjusted return on equity reached 19.2%.
Segment results were largely positive. Adjusted net investment income climbed 10% to $6.0 billion, supported by higher variable investment income. MetLife Investment Management reported total assets under management (AUM) of $723.4 billion, up 14%, reflecting business growth and the addition of PineBridge Investments. Across regions, the company highlighted broad-based volume growth and favorable underwriting as main drivers of the profit increase.
Market Reaction and Investor Sentiment
MetLife shares closed at $102.89 on the day results were released, showing a muted initial response to a quarter that paired strong top-line growth with a modest miss on net premiums earned. The stock has advanced roughly 5% over the past three months and about 30% over the trailing twelve months, outpacing the broader market. Analysts had been generally constructive heading into the print, with MetLife recording 13 positive EPS revisions and no negative revisions in the 90 days prior. The flat-to-slightly-positive reaction suggests investors balanced the earnings beat and robust investment income against the premiums shortfall and a book value per share figure that landed marginally below consensus.
Forward Outlook and Key Factors to Monitor
Looking ahead, I’m watching whether MetLife can convert its strong investment results into more durable premium growth. Net premiums earned, which form the core of recurring revenue, missed expectations this quarter, so future reports will be scrutinized for signs that underwriting and sales momentum are accelerating across the U.S., Asia, and Latin America segments.
Investment income will stay a central theme. The 10% rise in adjusted net investment income and the 49% increase in variable investment income reflect favorable market conditions, though these figures can fluctuate. Higher interest rates have generally supported portfolio yields, and any shift in the rate environment could affect both investment returns and demand for annuity and retirement products.
Capital management remains worth tracking given the notable 35.6% increase in book value per share. Metrics such as adjusted return on equity and expense ratios will show whether growth is translating into improved profitability. Finally, the expansion of MetLife Investment Management, including the PineBridge Investments addition, positions the firm for higher fee-based earnings, though investors will track whether that growth offsets any slowdown in traditional insurance premiums.
Using Tickeron’s AI Tools for Research
In my own work, I often turn to Tickeron’s AI Screener when evaluating names like MET alongside peers in the insurance sector. The tool lets me filter on technical patterns, fundamentals, trends, volatility, and AI-driven signals to build more informed watchlists quickly. It has become a practical part of my routine for spotting opportunities across industries without relying solely on manual screening.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MET in +1.24% Uptrend, growing for three consecutive days on November 03, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 227 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 26 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 68 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
The Moving Average Convergence Divergence Histogram (MACD) for MET turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 31 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 25 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.331) is slightly higher than the industry average of (1.354). P/E Ratio (19.139) is within average values for comparable stocks, (20.301). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of insurance and financial services and also function as bank holding company
Industry LifeHealthInsurance
Advertisement